Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $978.0M |
| Sales growthchange from the year before | -1.2% |
| Net marginshare of sales kept as profit | 8.1% |
| Return on equityprofit vs. shareholders' accounting value | 12.4% |
3 insiders sold $858K on the open market.
| Bixenman Dennis JosephDirector | SoldAug 4 | 11,250 shat $19.26 · $217K |
| King David CharlesDirector | SoldAug 4 | 9,000 shat $19.33 · $174K |
| Deas Noland Rone JrSenior Vice President | SoldAug 4 | 24,000 shat $19.47 · $467K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy